Catalan
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Pàgina 1 des de 28 resultats
Method of treating a human being for a class of neurological defects and seizure disorders
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
BACKGROUND OF THE INVENTION
1. Field of Invention
This invention relates to treatment of human beings for conditions associated with deficiencies in the N-6-trimethyl-L-lysine (TML) pathway affecting biosynthesis of carnitine. Such conditions include: (1) seizures, myoclonic seizures, epilepsy,
Compositions and methods for treatment of neurological symptoms associated with alcohol-withdrawal and for convulsive seizure
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
FIELD OF THE INVENTION
Aspects of the present invention relate generally to alcohol withdrawal syndrome (AWS), and isoprenoid-based compounds, and more particularly to pharmaceutical compositions comprising calcium channel blockers (e.g., isoprenoids such as farnesol and/or farnesol analogues or
Seizure and movement monitoring apparatus
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
BACKGROUND OF THE INVENTION
This invention relates to seizure monitors, and more particularly relates to means for monitoring movements attributable to seizures and convulsions of patients having epilepsy or other seizure disorders.
As is well known by those skilled in the art, it is common practice
Method for treating convulsions and epilepsy with organic copper compounds
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
FIELD OF THE INVENTION
The present invention relates to a method of treating convulsions, including convulsive tremors and convulsive seizures, and, in particular, epilepsy, with organic copper compounds.
BACKGROUND OF THE INVENTION
Copper is a normal component of the human brain, which contains
Method for treating convulsions and epilepsy with organic copper compounds
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
FIELD OF THE INVENTION
The present invention relates to a method of treating convulsions, including convulsive tremors and convulsive seizures, and, in particular, epilepsy, with organic copper compounds.
BACKGROUND OF THE INVENTION
Copper is a normal component of the human brain, which contains
Method for treating convulsions and epilepsy with organic copper compounds
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
FIELD OF THE INVENTION
The present invention relates to a method of convulsions, including convulsive tremors and convulsive seizures, and, in particular, epilepsy, with organic copper compounds.
BACKGROUND OF THE INVENTION
Copper is a normal component of the human brain, which contains about 370 mg
Method for treating convulsions and epilepsy with organic copper compounds
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
FIELD OF THE INVENTION
The present invention relates to a method of treating convulsions, including convulsive tremors and convulsive seizures, and, in particular, epilepsy, with organic copper compounds.
BACKGROUND OF THE INVENTION
Copper is a normal component of the human brain, which contains
Digital electromagnetic pulse generator
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT
Not applicable
INCORPORATION-BY-REFERENCE OF MATERIAL SUBMITTED ON A COMPACT DISC
Not applicable
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates generally to medical equipment for Magnetic Resonance Therapy
Methods of treating developmental disorders with biguanides
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
TECHNICAL FIELD
Methods of treating developmental disorders with biguanides are provided.
BACKGROUND
Biguanides such as metformin, buformin and phenformin have been used as antihyperglycemic agents in the treatment of diabetes. Metformin decreases hepatic glucose production, decreases intestinal
Methods of treating developmental disorders with biguanides
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
TECHNICAL FIELD
Methods of treating developmental disorders with biguanides are provided.
BACKGROUND
Biguanides such as metformin, buformin and phenformin have been used as antihyperglycemic agents in the treatment of diabetes. Metformin decreases hepatic glucose production, decreases intestinal
Thermal excitation of sensory resonances
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
BACKGROUND OF THE INVENTION
In man, the nervous system responds markedly to certain sensory signals in a narrow band of frequencies near 1/2 Hz; the response to the sensory signals includes sleepiness, drowsiness, relaxation, a tonic smile, ptosis of the eyelids, the feeling of a "knot" in the
Pulsative manipulation of nervous systems
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
BACKGROUND OF THE INVENTION
The invention relates to influencing the nervous system of a subject by pulsative stimulation of sensory receptors, relying on the mechanisms of sensory resonance and frequency modulation of spontaneous spike patterns, as discussed in U.S. Pat. No. 5,782,874. [1]. In that
2,5-dialkyl-4-H/halo/ether-phenol compounds
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
FIELD OF THE INVENTION
This invention relates to compounds having beneficial effects in the central nervous system (CNS) of mammals. More specifically, this invention relates to compounds that prevent or halt ongoing seizures in mammals, and thus have antiepileptic/anticonvulsant activities that are
Ethinyl-pyrazole derivative
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
CROSS REFERENCE TO RELATED APPLICATIONS
This application is a National Stage of International Application No. PCT/JP2011/067394 filed Jul. 29, 2011, claiming priority based on Japanese Patent Application No. 2010-170732 filed Jul. 29, 2010, the contents of all of which are incorporated herein by
7-piperidinoalkyl-3, 4-Dihydroquinolone derivative
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
CROSS REFERENCE TO RELATED APPLICATIONS
This is a National Stage of International Application No. PCT/JP2009/067441 filed Sep. 30, 2009, claiming priority based on Japanese Patent Application No. 2008-257072 filed Oct. 2, 2008, the contents of all of which are incorporated herein by reference in
La base de dades d’herbes medicinals més completa avalada per la ciència
- Funciona en 55 idiomes
- Cures a base d'herbes recolzades per la ciència
- Reconeixement d’herbes per imatge
- Mapa GPS interactiu: etiqueta les herbes a la ubicació (properament)
- Llegiu publicacions científiques relacionades amb la vostra cerca
- Cerqueu herbes medicinals pels seus efectes
- Organitzeu els vostres interessos i estigueu al dia de les novetats, els assajos clínics i les patents
Escriviu un símptoma o una malaltia i llegiu sobre herbes que us poden ajudar, escriviu una herba i vegeu malalties i símptomes contra els quals s’utilitza.
* Tota la informació es basa en investigacions científiques publicades
